Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ELAVL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIMM44 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTXN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNAPC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP2K7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCL25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC8E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CERS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD320 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NDUFA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on